Clinical significance of cathepsin D in primary ovarian cancer

European Journal of Cancer

Volumn 30, Issue 7, 1994, Pages 935-940

  Scambia, G ^a   Panici, P B ^a   Ferrandina, G ^a   Salerno, G ^a   D'Agostino, G ^a   Distefano, M ^a   De Vincenzo, R ^a   Ercoli, A ^a   Mancuso, S ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

cathepsin D; ovarian cancer; prognosis

Indexed keywords

CATHEPSIN D; CISPLATIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DRUG RESPONSE; FEMALE; HUMAN; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

ADULT; AGED; CATHEPSIN D; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMAN; IMMUNORADIOMETRIC ASSAY; MIDDLE AGE; MULTIVARIATE ANALYSIS; OVARIAN NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; SURVIVAL ANALYSIS;

EID: 0028049522     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(94)90118-X     Document Type: Article

References (30)

1. Proteolytic enzymes in tumor invasion and degradation of host extracellular matrices
2. Estradiol induces proteins in the MCF-7 human breast cancer cell line
3. The 52 kDa estrogen induced protein secreted by MCF-7 cells is a lysosomal acidic protease
4. Estradiol increases the secretion by MC57 cells of several lysosomial proenzymes
5. Estrogen-induced lysosomal proteases secreted by breast cancer cells: A role in carcinogenesis?
6. Cathepsin D in breast cancer: from molecular and cellular biology to clinical applications
7. Autoendocrine growth stimulation of the MCF-7 breast cancer cells by the estrogen regulated 52 KDa protein
8. Association between high concentrations of Mr 52000 Cathepsin D and poor prognosis in primary human breast cancer
9. Cathepsin D and prognosis in breast cancer
10. Prognostic significance of Cathepsin D in patients with breast cancer
11. Prognostic significance of the estrogen-regulated protein, Cathepsin D, in breast cancer
12. Intracellular Cathepsin D and prognosis in node-negative breast cancer (NNBC)
13. Estradiol stimulates cell growth and secretion of procathepsin D and a 120 kilodalton protein in the human ovarian cancer cell line BG-1
14. Characterization of a latent cysteine proteinase from ascitic fluid as a high molecular weight form of Cathepsin B
15. Cathepsin D assay in ovarian cancer: correlation with pathological features and receptors for estrogen, progesterone and epidermal growth factor
16. 2) cisplatin-induced neurotoxicity in primary advanced ovarian cancer patients
17. Cathepsin D assay in primary breast cancer and lymph nodes: relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasiveness
18. Cathepsin D in primary endometrial and cervical tumors: relationship with histopathological parameters and with estrogen, progesterone, and epidermal growth factor receptors
19. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye-binding
20. EORTC Breast Cancer Cooperative Group revision of the standards for the assessment of hormone receptors in human breast cancer
21. Epidermal growth factor receptor in human breast cancer: correlation with steroid hormone receptors and axillary lymph node involvement
22. Significance of epidermal growth factor receptor in advanced ovarian cancer
23. Nonparametric Estimation from Incomplete Observations
24. Evaluation of survival data and two new rank order statistics arising in its consideration.
25. Regression models and life table
26. Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency
27. Immunoenzymatic assay of Mr 52,000 Cathepsin D in 182 breast cancer cytosols: low correlation with other prognostic parameters
28. Estrogens and growth factors induce the mRNA of the 52 K-pro-cathepsin D secreted by breast cancer cells
29. Differential regulation of cathepsin D by sex steroids in mammary cancer and uterine cells